A study presented at the 2023 annual meeting of the American Academy of Orthopaedic Surgeons found no benefits in pain scores, opioid consumption or hospital length of stay for the multimodal analgesic regimen that was being investigated.
The authors of the study said additional research is needed to discover new ways of optimizing pain management while minimizing postoperative opioid consumption, as hip arthroscopy utilization continues to increase, according to the report.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.